Brain damage in preterm infants: Etiological pathways

Annali dell'Istituto Superiore di Sanita

Volumn 41, Issue 2, 2005, Pages 229-237

  Arpino, Carla ^a,b   D'Argenzio, Luigi ^a   Ticconi, Carlo ^a   Di Paolo, Ambrogio ^a   Stellin, Vincenzo ^a   Lopez, Luisa ^b   Curatolo, Paolo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Centro Prevenzione e Riabilitazione per l'Infanzia e l'Adolescenza E Litta   (Italy)

Author keywords

Brain damage; Genetic susceptibility; Hypoxia; Inflammation; Ischemia; Preterm

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; CELL ADHESION MOLECULE; CILIARY NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; CYTOCHROME C; CYTOKINE; GAMMA INTERFERON; GLUTAMIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTHROMBIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

APOPTOSIS; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN ISCHEMIA; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; ENCEPHALOMALACIA; GENETIC SUSCEPTIBILITY; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; INFLAMMATION; PATHOGENESIS; PREMATURITY; REVIEW; RISK FACTOR; WHITE MATTER;

ADULT; BIRTH INJURIES; BRAIN DAMAGE, CHRONIC; CEREBRAL PALSY; CHORIOAMNIONITIS; CYTOKINES; DEVELOPMENTAL DISABILITIES; EPILEPSY; FEMALE; FETAL DISEASES; FETAL HYPOXIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION MEDIATORS; LEARNING DISORDERS; MALE; MENTAL RETARDATION; MODELS, NEUROLOGICAL; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 31644451584     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2002. Natl Vital Stat Rep 2003;52(10):1-113.
2. Hagberg B, Hagberg G, Beckung E, Uvebrant P. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94. Acta Paediatr 2001;90(3):271-7.
3. Pleacher MD, Vohr BR, Katz KH, Ment LR, Allan WC. An evidence-based approach to predicting low IQ in very preterm infants from the neurological examination: outcome data from the indomethacin. Indomethacin Intraventricular Hemorrhage Prevention Trial Pediatrics 2004;113(2):416-9.
4. Aylward GP. Cognitive and neuropsychological outcomes: more than IQ scores. Ment Retard Dev Disabil Res Rev 2002;8(4):234-40.
5. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. Jama 2002;288(6):728-37.
6. Vohr BR, Wright LL, Dusick AM, Mele L, Verter J, Steichen JJ, Simon NP, Wilson DC, Broyles S, Bauer CR, Delaney-Black V, Yolton KA, Fleisher BE, Papile LA, Kaplan MD. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000;105(6):1216-26.
7. Deguchi K, Oguchi K, Takashima S. Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr Neurol 1997;16(4):296-300.
8. Kuban K, Sanocka U, Leviton A, Allred EN, Pagano M, Dammann O, Share J, Rosenfeld D, Abiri M, Di Salvo D, Doubilet P, Kairam R, Kazam E, Kirpekar M, Schonfeld S. White matter disorders of prematurity: association with intraventricular hemorrhage and ventriculomegaly. The Developmental Epidemiology Network. J Pediatr 1999;134(5):539-46.
9. Roelants-van Rijn AM, Groenendaal F, Beek FJ, Eken P, van Haastert IC, de Vries LS. Parenchymal brain injury in the preterm infant: comparison of cranial ultrasound, MRI and neurodevelopmental outcome. Neuropediatrics 2001;32(2):80-9.
10. Dale A, Stanley FJ. An epidemiological study of cerebral palsy in Western Australia, 1956-1975. II: Spastic cerebral palsy and perinatal factors. Dev Med Child Neurol 1980;22(1):13-25.
11. Curatolo P, Arpino C, Stazi MA, Medda E. Risk factors for the co-occurrence of partial epilepsy, cerebral palsy and mental retardation. Dev Med Child Neurol 1995;37(9):776-82.
12. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O. Kuban K, Van Marter LJ, Pagano M, Hegyi T, Hiatt M, Sanocka U, Shahrivar F, Abiri M, Disalvo D, Doubilet P, Kairam R, Kazam E, Kirpekar M, Rosenfeld D, Schonfeld S, Share J, Collins M, Genest D, Shen-Schwarz S, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators Pediatr Res 1999;46(5):566-75.
13. Arpino C, Domizio S, Carrieri MP, Brescianini DS, Sabatino MG, Curatolo P. Prenatal and perinatal determinants of neonatal seizures occurring in the first week of life. J Child Neurol 2001;16(9):651-6.
14. Saliba E, Marret S. Cerebral white matter damage in the preterm infant: pathophysiology and risk factors. Semin Neonatal 2001;6(2):121-33.
15. Terzidou V, Bennett P. Maternal risk factors for fetal and neonatal brain damage. Biol Neonate 2001;79(3-4):157-62.
16. Milsom I, Ladfors L, Thiringer K, Niklasson A, Odeback A, Thornberg E. Influence of maternal, obstetric and fetal risk factors on the prevalence of birth asphyxia at term in a Swedish urban population. Acta Obstet Gynecol Scand 2002;81(10):909-17.
17. Willoughby RE, Nelson KB. Chorioamnionitis and brain injury. Clin Perinatol 2002;29(4):603-21.
18. Sullivan MH, Steel J, Kennea N, Feldman RG, Edwards AD. The role of intrauterine bacteria in brain injury. Acta Paediatr Suppl 2004;93(444):4-5.
19. Arpino C, Curatolo P, Stazi MA, Pellegri A, Vlahov D. Differing risk factors for cerebral palsy in the presence of mental retardation and epilepsy. J Child Neurol 1999;14(3):151-5.
20. Stanley FJ, Blair E, Alberman E. Cerebral Palsies: Epidemiology & Causal Pathways. London: Mac Keith Press; 2000.
21. Inder TE, Volpe JJ. Mechanisms of perinatal brain injury. Semin Neonatal 2000;5(1):3-16.
22. Dammann O, Kuban KC, Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev 2002;8(1):46-50.
23. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Hum Dev 2004;79(1):1-15.
24. Yager JY. Animal models of hypoxic-ischemic brain damage in the newborn. Semin Pediatr Neurol 2004;11(1):31-46.
25. Volpe JJ. Neurology of the newborn. London: W.B. Saunders; 2000.
26. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50(5):553-62.
27. du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002;15(2):151-7.
28. Berger R, Garnier Y. Perinatal brain injury. J Perinat Med 2000;28(4):261-85.
29. Johnston MV, Trescher WH, Ishida A, Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res 2001;49(6):735-41.
30. Halterman MW, Miller CC, Federoff HJ. Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci 1999;19(16):6818-24.
31. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82(1):47-95.
32. Jensen A, Garnier Y, Middelanis J, Berger R. Perinatal brain damage-from pathophysiology to prevention. Eur J Obstet Gynecol Reprod Biol 2003;110(Suppl 1)570-9.
33. Buonocore G, Perrone S. Biomarkers of hypoxic brain injury in the neonate. Clin Perinatol 2004;31(1):107-16.
34. Fern R, Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 2000;20(1):34-42.
35. Palmer C, Towfighi J, Roberts RL, Heitjan DF. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993;33(4 Pt 1):405-11.
36. Hamada Y, Hayakawa T, Hattori H, Mikawa H. Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 1994;35(1):10-4.
37. Patkai J, Mesples B, Dommergues MA, Fromont G, Thornton EM, Renauld JC, Evrard P, Gressens P. Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr Res 2001;50(2):222-30.
38. Kristian T. Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium 2004;36(34):221-33.
39. Englund E. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis 2002;13(Suppl 2):11-5.
40. Counsell SJ, Rutherford MA, Cowan FM, Edwards AD. Magnetic resonance imaging of preterm brain injury. Arch Dis Child Fetal Neonatal Ed 2003;88(4):F269-74.
41. Peterson BS. Brain imaging studies of the anatomical and functional consequences of preterm birth for human brain development. Ann N Y Acad Sci 2003;1008:219-37.
42. McQuillen PS, Ferriero DM. Selective vulnerability in the developing central nervous system. Pediatr Neurol 2004;30(4): 227-35.
43. Russ A, Hand IL. Preterm brain injury: imaging and neurodevelopmental outcome. Am J Perinatol 2004;21(3):167-72.
44. Takashima S, Tanaka K. Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol 1978;35(1):11-6.
45. Nelson MD, Jr., Gonzalez-Gomez I, Gilles FH. Dyke Award. The search for human telencephalic ventriculofugal arteries. Am J Neuroradiol 1991;12(2):215-22.
46. Kuban KC. White-matter disease of prematurity, periventricular leukomalacia, and ischemic lesions. Dev Med Child Neurol 1998;40(8):571-3.
47. Tuor UI, Grewal D. Autoregulation of cerebral blood flow: influence of local brain development and postnatal age. Am J Physiol 1994;267(6 Pt 2):H2220-8.
48. McQuillen PS, Sheldon RA, Shatz CJ, Ferriero DM. Selective vulnerability of subplate neurons after early neonatal hypoxia-ischemia. J Neurosci 2003;23(8):3308-15.
49. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42(1):1-8.
50. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002;8(1):3-13.
51. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990;85(5):1392-400.
52. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992;166(5):1576-87.
53. Ticconi C, Lye SJ. Placenta and fetal membranes in human parturition and preterm delivery - a workshop report. Placenta 2002;23(Suppl A):S149-52.
54. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002;8(1):25-9.
55. Minagawa K, Tsuji Y, Ueda H, Koyama K, Tanizawa K, Okamura H, Hashimoto-Tamaoki T. Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine 2002;17(3):164-70.
56. Kaukola T, Satyaraj E, Patel DD, Tchernev VT, Grimwade BG, Kingsmore SF, Koskela P, Tammela O, Vainionpaa L, Pihko H, Aarimaa T, Hallman M. Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol 2004;55(2):186-94.
57. Nelson KB, Grether JK, Dambrosia JM, Walsh E, Kohler S, Satyanarayana G, Nelson PG, Dickens BF, Phillips TM. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 2003;53(4):600-7.
58. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995;2(4):241-8.
59. Saito S. Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol 2001;52(1-2):15-33.
60. John GR, Lee SC, Brosnan CF. Cytokines: powerful regulators of glial cell activation. Neuroscientist 2003;9(1):10-22.
61. Hedtjarn M, Mallard C, Arvidsson P, Hagberg H. White matter injury in the immature brain: role of interleukin-18. Neurosci Lett 2005;373(1):16-20.
62. Kadhim H, Tabarki B, De Prez C, Sebire G. Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathol (Berl) 2003;105(3):209-16.
63. Folkerth RD, Keefe RJ, Haynes RL, Trachtenberg FL, Volpe JJ, Kinney HC. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol 2004;14(3):265-74.
64. Mehler MF, Kessler JA. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci 1997;20(8): 357-65.
65. Ensoli F, Fiorelli V, Muratori DS, De Cristofaro M, Vincenzi L, Topino S, Novi A, Luzi G, Sirianni MC. Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators? Crit Rev Immunol 1999;19(2):97-116.
66. Szelenyi J. Cytokines and the central nervous system. Brain Res Bull 2001;54(4):329-38.
67. Mehler MF, Marmur R, Gross R, Mabie PC, Zang Z, Papavasiliou A, Kessler JA. Cytokines regulate the cellular phenotype of developing neural lineage species. Int J Dev Neurosci 1995;13(3-4):213-40.
68. Baud O, Emilie D, Pelletier E, Lacaze-Masmonteil T, Zupan V, Fernandez H, Dehan M, Frydman R, Ville Y. Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Br J Obstet Gynaecol 1999;106(1):72-7.
69. Dammann O, Phillips TM, Allred EN, O'Shea TM, Paneth N, Van Marter LJ, Bose C, Ehrenkranz RA, Bednarek FJ, Naples M, Leviton A. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 2001;13(4):234-9.
70. Hagberg H. No correlation between cerebral palsy and cytokines in postnatal blood of preterms. Pediatr Res 2003;53(4):544-5.
71. Martin-Ancel A, Garcia-Alix A, Pascual-Salcedo D, Cabanas F, Valcarce M, Quero J. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 1997;100(5):789-94.
72. Savman K, Blennow M, Gustafson K, Tarkowski E, Hagberg H. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res 1998;43(6):746-51.
73. Dammann O, Leviton A. Brain damage in preterm newborns: might enhancement of developmentally regulated endogenous protection open a door for prevention? Pediatrics 1999;104(3 Pt 1):541-50.
74. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000;10(1):95-112.
75. Scher M. Perinatal asphyxia: timing and mechanisms of injury in neonatal encephalopathy. Curr Neurol Neurosci Rep 2001;1(2):175-84.
76. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 2002;22(12):1399-419.
77. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003;108(19):2317-22.
78. Chiesa C, Pellegrini G, Panero A, De Luca T, Assumma M, Signore F, Pacifico L. Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest 2003;33(4):352-8.
79. Silveira RC, Procianoy RS. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 2003;143(5):625-9.
80. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004;4(1):2.
81. Montaner J, Rovira A, Molina CA, Arenillas JF, Ribo M, Chacon P, Monasterio J, Alvarez-Sabin J. Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 2003;23(12):1403-7.
82. Moller K, Strauss GI, Qvist J, Fonsmark L, Knudsen GM, Larsen FS, Krabbe KS, Skinhoj P, Pedersen BK. Cerebral blood flow and oxidative metabolism during human endotoxemia. J Cereb Blood Flow Metab 2002;22(10):1262-70.
83. Yanowitz TD, Jordan JA, Gilmour CH, Towbin R, Bowen A, Roberts JM, Brozanski BS. Hemodynamic disturbances in premature infants born after chorioamnionitis: association with cord blood cytokine concentrations. Pediatr Res 2002;51(3):310-6.
84. Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E, Mannick JA, Lederer JA. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 2003;171(3):1473-83.
85. Kariko K, Weissman D, Welsh FA. Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 2004;24(11):1288-304.
86. Yang L, Sameshima H, Ikeda T, Ikenoue T. Lipopolysaccharide administration enhances hypoxic-ischemic brain damage in newborn rats. J Obstet Gynaecol Res 2004;30(2):142-7.
87. Ishikawa M, Zhang JH, Nanda A, Granger DN. Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front Biosci 2004;9:1339-47.
88. Benchoua A, Braudeau J, Reis A, Courtaud C, Onteniente B. Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J Cereb Blood Flow Metab 2004;24(11):1272-9.
89. Dietrich N, Thastrup J, Holmberg C, Gyrd-Hansen M, Fehrenbacher N, Lademann U, Lerdrup M, Herdegen T, Jaattela M, Kallunki T. JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways. Cell Death Differ 2004;11(3):301-13.
90. Harding DR, Dhamrait S, Whitelaw A, Humphries SE, Marlow N, Montgomery HE. Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm birth? Pediatrics 2004;114(4):941-7.
91. Halliday JL, Reddihough D, Byron K, Ekert H, Ditchfield M. Hemiplegic cerebral palsy and the factor V Leiden mutation. J Med Genet 2000;37(10):787-9.
92. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S, Rechavi G, Inbal A. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31(6):1283-8.
93. Nowak-Gottl U, Strater R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94(11): 3678-82.
94. Pezzini A, Grassi M, Del Zotto E, Archetti S, Spezi R, Vergani V, Assanelli D, Caimi L, Padovani A. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke 2005;
95. Lee BC, Ahn SY, Doo HK, Yim SV, Lee HJ, Jin SY, Hong SJ, Lee SH, Kim SD, Seo JC, Leem KH, Chung JH. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci Lett 2004;357(1):33-6.
96. Revilla M, Obach V, Cervera A, Davalos A, Castillo J, Chamorro A. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett 2002;324(1):29-32.
97. Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D'Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB. Polymorphisms of the interleukin-1 beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005;25(1):222-7.
98. Vermeulen GM, Bruinse HW, de Vries LS. Perinatal risk factors for adverse neurodevelopmental outcome after spontaneous birth. Eur J Obstet Gynecol Reprod Biol 2001;99(2):207-12.
99. Inder TE, Anderson NJ, Spencer C, Wells S, Volpe JJ. White matter injury in the premature infant: a comparison between serial cranial sonographic and MR findings at term. AJNR Am J Neuroradiol 2003;24(5):805-9.
100. Larroque B, Marret S, Ancel PY, Arnaud C, Marpeau L, Supermant K, Pierrat V, Roze JC, Matis J, Cambonie G, Burguet A, Andre M, Kaminski M, Breart G. White matter damage and intraventricular hemorrhage in very preterm infants: the EPIPAGE study. J Pediatr 2003;143(4):477-83.
101. De Vries LS, Van Haastert IL, Rademaker KJ, Koopman C, Groenendaal F. Ultrasound abnormalities preceding cerebral palsy in high-risk pretern infants. J Pediatr 2004;144(6):815-20.